Nutrition in Gastrointestinal Tumors
Pancreatic CancerOesophageal Cancer9 moreMalnutrition and loss of muscle mass frequently occur in patients undergoing chemotherapy and can negatively effect therapy outcome. Especially patients with cancer of the gastrointestinal tract are often affected by malnutrition. Therefore, this study aims to examine changes in nutritional status of patients with cancer of the gastrointestinal tract during chemotherapy. Findings of this study will help to improve nutritional treatment of patients undergoing chemotherapy.
Community-based Neuroendocrine Tumor (NET) Research Study
Gastroenteropancreatic Neuroendocrine TumorsThe purpose of this trial is to assess time to disease progression of patients with locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors treated with Lanreotide Depot. This is an observational study therefore all data collected will be in accordance with the routine practice of physicians.
Imaging of Radiolabeled White Blood Cells in Patients With Non-Hodgkin's Lymphoma
LymphomaSmall Intestine CancerRATIONALE: Measuring the number of radiolabeled white blood cells in non-Hodgkin's lymphoma tumors may help doctors predict how well patients will respond to treatment, and may help the study of cancer in the future. PURPOSE: This study is measuring radiolabeled white blood cells in patients with non-Hodgkin's lymphoma.
Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck...
Anal CancerColorectal Cancer9 moreRATIONALE: Gathering information about patients' quality of life during radiation therapy for cancer may help doctors plan the best treatment. PURPOSE: This randomized clinical trial is studying quality of life in patients undergoing radiation therapy for primary lung cancer, head and neck cancer, or gastrointestinal cancer.
Viewpoints on the Social Representations and Rationale Concerning the Choices of Patients, Doctors...
Non-resectable Metastatic Cancer of the LungNon-resectable Metastatic Cancer of the Colon6 moreReflexion on the therapeutic strategies to implement in patients at the end of life is advancing rapidly in France. However, beyond the choices presented to patients, sometimes even the decision to carry on, to limit or to stop treatments is also questioned. This decision is subjective; it is influenced by the patient's representation system (emotions, beliefs, values, practices, etc). In addition, even though he or she is the focus of the decision, the patient is not alone; other actors, accompanying the patient, play an important role in the final decision making. These actors, namely the doctors and close relatives, are also influenced in their decision making. This coexistence of representation systems may interfere with objective indicators that help in decision making (functional, clinical and biological) or with the knowledge acquired by doctors in their training and may complicate the decision-making process.
Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma
Colorectal NeoplasmIntestinal Neoplasms7 moreThe research product, registered as a nutritional supplement (Ocoxin®, oral solution), manufactured by Laboratorios Catalysis S. L., comes in the form of single-dose vials of 30 ml. It will be used at a rate of 60 ml daily (1 vial every 12 hours). Our main objective is To evaluate the effect of Ocoxin®-Viusid® on the quality of life of patients with metastatic colorectal adenocarcinoma. Our hypothesis is that the administration of the nutritional supplement Ocoxin®-Viusid® it is expected to improve the quality of life and enhance tolerance to chemotherapy in at least 70% of patients.
Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for...
Brain and Central Nervous System TumorsLymphoma5 moreRATIONALE: Finishing an antibiotic regimen at home may be as effective as receiving it in the hospital. It is not yet known whether early hospital discharge is as effective as standard inpatient care in cancer patients receiving antibiotics for febrile neutropenia. PURPOSE: This randomized phase III trial is studying early hospital discharge and comparing it with standard inpatient care in cancer patients receiving antibiotics for febrile neutropenia.
Gastrointestinal Anastomosis Using MonoPlus® Suture
Gastrointestinal Stromal TumorsGastrointestinal Neoplasms5 moreThe primary aim of this study is to collect clinical data on the performance of MonoPlus® suture applied in routine clinical practice. Diverse parameters are to be used to assess the safety and efficacy of MonoPlus® suture for gastrointestinal anastomosis construction. This study has been designed to implement an action within the framework of a proactive Post Market Clinical Follow up (PMCF) activity.
Quality-Of-Life QLQ-GINET21 Questionnaire In The Treatment Of Patients With Gastrointestinal Neuroendocrine...
Gastrointestinal Neuroendocrine TumoursThe purpose of this study is to evaluate the utility of the QLQ-GINET21 in making clinical and therapeutic decisions.
Quality of Life, Treatment Experience and Cost of Treatment With Somatostatin Analogues in Patients...
Gastroenteropancreatic Neuroendocrine TumoursData from this study will contribute additional knowledge regarding patient outcomes and direct somatostatin analogue (SSA) treatment related costs in clinical practice in the Nordic countries. Such knowledge can be of importance in a treatment decision, decision support for development of care, follow up and training of both patients and primary care nurses.